In humans and mice, inactivating mutations in fibroblast growth factor receptor 1 (Fgfr1) lead to gonadotropin-releasing hormone (GnRH) deficiency and a host of downstream reproductive disorders. This evidence concerns the gene GNRH1 and hyperinsulinemic hypoglycemia, familial, 4.